Lactate dehydrogenase isoenzymes in the human hypertrophic heart

Insights

Lactate dehydrogenase isoenzymes in human hearts shift during hypertrophy and ischemia. This change is linked more to increased fibrous tissue than myocardial cell alterations.

Area of Science:

  • Biochemistry
  • Cardiology
  • Pathology

Background:

  • Lactate dehydrogenase (LDH) is an enzyme crucial for cellular energy metabolism.
  • LDH exists in various isoenzyme forms, reflecting tissue-specific metabolic states.
  • Alterations in cardiac structure, such as hypertrophy and ischemia, can impact myocardial enzyme profiles.

Purpose of the Study:

  • To investigate the distribution of lactate dehydrogenase isoenzymes in human hearts.
  • To compare LDH isoenzyme patterns in normal, hypertrophic, and ischemic hypertrophic hearts.
  • To determine the correlation between LDH isoenzyme shifts and cardiac tissue changes.

Main Methods:

  • Autopsy human heart tissue samples were analyzed.
  • Lactate dehydrogenase isoenzyme distribution was measured.
  • Histological analysis of myocardial and fibrous tissue proportions was performed.

Main Results:

  • A distinct shift in LDH isoenzyme distribution was observed in hypertrophic and ischemic hypertrophic hearts compared to normal hearts.
  • This isoenzyme shift correlated more strongly with an increased proportion of fibrous tissue.
  • The changes in LDH isoenzyme patterns were less associated with alterations in myocardial cells themselves.

Conclusions:

  • LDH isoenzyme analysis can serve as a biomarker for cardiac pathology.
  • Fibrous tissue proliferation in the heart is a significant factor influencing LDH isoenzyme profiles in disease states.
  • Further research into LDH isoenzymes may elucidate mechanisms of cardiac remodeling and disease progression.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...